Clin2
NCT06626178Possibly a fitRecruiting

AI for preventing smoking-related diseases

Lung Cancer Screening ProgramArtificial Intelligence (AI)

Treatments studied

Part of Cancer, Lungs & breathing clinical trials.

This study uses artificial intelligence to analyze CT scans and other health data to better identify people at risk for smoking-related diseases like lung cancer. Researchers hope to improve early detection and prevention.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,840 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 50 or older.
  • You are a current smoker, or quit within the last 15 years.
  • You have smoked at least 20 pack-years (for example, 1 pack a day for 20 years, or 2 packs a day for 10 years).
  • Your estimated 6-year risk of getting lung cancer is above 1.2%, based on a standard risk model.
  • You can provide signed consent to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06988579Recruiting
AI-assisted lung cancer screening study

This trial tests whether using AI to help radiologists read lung CT scans can find cancer earlier and lower healthcare costs. You may qualify if you are at risk for lung cancer and have not been screened recently.

Guangzhou, Guangdong
NCT06684418Recruiting
AI to find hidden cancer spread in early lung cancer

This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.

Shanghai
NCT06931782Enrolling by invitation
AI for respiratory disease screening study

This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.

Guangzhou, Guangdong
NCT07458425Recruiting
Lung cancer screening study using AI

This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.

Chicago, Illinois
NCT07280559Not yet recruiting
AI-assisted lung cancer screening with low-dose CT

This trial uses artificial intelligence to improve low-dose CT scans for early lung cancer detection. If you are at higher risk due to smoking or family history, or just want a routine check, you may be able to join.

Taipei, Taiwan
NCT05704920Recruiting
AI-based support for lung cancer screening scans

This trial tests whether using artificial intelligence (computer pattern-recognition) with lung screening images can help identify people who may have lung cancer earlier. It’s meant for people at higher risk because of their smoking history, who can follow the screening steps.

Nice, Alpes-maritimes

Hear when a new Artificial Intelligence (AI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.